This content is machine translated Comorbid iron deficiency in heart failure Evidence-based beneficial effects of intravenous iron supplementation. Iron deficiency is common in heart failure patients. In addition to a reduction in exercise capacity and quality of life, an increased risk of mortality is associated with it –…
View Post 4 min This content is machine translated Heart failure SGLT2 inhibitors – are the new preparations more than just good antidiabetic agents? SGLT2 inhibitors have been used successfully for some time in the treatment of diabetes mellitus. They are associated with effective blood glucose lowering through increased renal glucose excretion. But they…
View Post 3 min This content is machine translated INOCA phenomenon and co. Late-Breaking News Highlights Despite the pandemic, the American College of Cardiology’s annual meeting, while not on-site in Chicago, still scored virtually. Numerous new findings with regard to both intervention strategies and pharmacological therapies…
View Post 3 min This content is machine translated Type 1 diabetes Despite known cardiac risk, many patients are undertreated Cardiac problems such as coronary artery disease and heart failure are among the most common and dangerous complications of type 1 diabetes. The mortality risk is significantly increased. Although this…
View Post 3 min This content is machine translated Hyperkalemia How the Guideline Comes to the Bedside: Hyperkalemia Management Up to Date Patients with chronic heart or kidney failure often suffer from hyperkalemia. The use of RAAS inhibitors in particular may increase the risk of this life-threatening electrolyte disturbance. Therefore, therapy of…
View Post 7 min This content is machine translated Supraventricular tachycardias ECG interpretation in SVT Supraventricular tachycardia (SVT) occurs in the general population with a prevalence of approximately 2-3/1000 population. Many people can be helped by adequate diagnosis and treatment of arrhythmias, and the correct…
View Post 3 min This content is machine translated Heart failure Empagliflozin Reduces Risk of Cardiovascular Death and Hospitalization Rate in Heart Failure Ingelheim, Germany and Indianapolis, USA – Results from the phase III EMPEROR-Reduced study in adults with heart failure with reduced ejection fraction (with and without diabetes) showed that empagliflozin was…
View Post 2 min This content is machine translated Atrial fibrillation Early rhythm control aims for better outcomes In patients with newly diagnosed AF, early initiation of rhythm control may reduce cardiovascular outcomes. Therapy with antiarrhythmic drugs and/or catheter ablation reduced cardiovascular deaths, strokes, and hospitalizations caused by…
View Post 4 min This content is machine translated Primary prevention of atherosclerosis Non-HDL cholesterol associated with long-term risk The criteria for cardiovascular risk stratification defined in the current guidelines of the European Society of Cardiology (ESC) form the basis for the calculation of an individual risk score. Non-HDL…
View Post 3 min This content is machine translated Alzheimer's and Co. Effective blood pressure therapy keeps dementia risk in check Dementia is an expression and consequence of various diseases. Due to demographic change, the prevalence is steadily increasing. A few years ago, it was possible to uncover a link between…
View Post 3 min This content is machine translated Diabetes Therapy Do GLP-1 receptor agonists contribute to stroke prophylaxis? The risk of suffering a stroke is massively higher for diabetics than in the general population. New data suggest that dulaglutide reduces the risk of ischemic stroke in diabetic patients…
